Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 2 4Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Withdrawn 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Breast Neoplasms 1889Carcinoma, Non-Small-Cell Lung 1350Prostatic Neoplasms 980Colorectal Neoplasms 851Multiple Myeloma 741Leukemia, Myeloid, Acute 725Neoplasms 691Lung Neoplasms 680Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 567Stomach Neoplasms 523Leukemia 511Recurrence 493Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 451Lymphoma, Non-Hodgkin 443Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 423Squamous Cell Carcinoma of Head and Neck 416Myelodysplastic Syndromes 416Head and Neck Neoplasms 404Brain Neoplasms 403Rectal Neoplasms 397Glioblastoma 375Carcinoma, Renal Cell 350Hodgkin Disease 338Esophageal Neoplasms 337

Interventions

efalizumab 1Minoxidil 1Immunoconjugates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Alopecia × Clear all
NCT07474558 2026-03-16

SCARLET-ICE

Jules Bordet Institute

Phase 2 Not yet recruiting
102 enrolled

Alopecia

NCT05778825 2026-02-20

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
10 enrolled

Alopecia

NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Northwestern University

Phase 2 Withdrawn
Lymphoid

Alopecia, Lymphoma, Follicular

NCT00515762 2011-08-09

Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling

Hospital San Carlos, Madrid

Phase 2 Completed
150 enrolled
Breast

Alopecia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡